miR-455-3p has superior diagnostic potential to PSA in peripheral blood for prostate cancer.
<h4>Background</h4>Prostate-specific antigen (PSA) is commonly used as a biomarker to diagnose and predict the course of prostate cancer (PCa). However, PSA detection is susceptible to changes in the physiologic environment, which may lead to some misdiagnosis. Thus, it is crucial to fin...
Saved in:
| Main Authors: | Yi Cen, Shourui Feng, Yuyu Xu, Churuo Zhang, Xiangjin Lin, Xuan Ye, Zeyu Zha, Haiyan Wang, Guangbin Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0317385 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
by: Jian Guo, et al.
Published: (2018-01-01) -
Robotic Prostatectomy Has a Superior Outcome in Larger Prostates and PSA Density Is a Strong Predictor of Biochemical Recurrence
by: S. Bishara, et al.
Published: (2014-01-01) -
miR-455 inhibits neuronal cell death by targeting TRAF3 in cerebral ischemic stroke
by: Yao ST, et al.
Published: (2016-12-01) -
Decreased miR-455-3p promotes diabetic retinopathy progression via modulating retinal endothelial proliferation and apoptosis
by: Weipeng Jiang, et al.
Published: (2025-07-01) -
MiR-455-5p Mitigates Interleukin-1 β-induced Chondrocyte Damage Linked to Osteoarthritis by Targeting TNFAIP8
by: Tao Zhang, et al.
Published: (2025-04-01)